Hi Rvajna,
I assume you are referring to the SP rather than the proposed treatment cost? In Hashan's article he makes a good case that NEU is potentially worth A$2-2.5b. Given our current A$1.1b MC one would say we are still very undervalued. As Jon has stated many times the key value drivers will be realised in 2023. Success with NNZ-2591 will see us exceed Hashan's valuation IMO.
If you are referring to the treatment being overpriced at potentially $150-250k; given we are yet to know what the price will be i cannot comment.
Trof Pricing - name your price, page-17
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.22 |
Change
0.240(1.20%) |
Mkt cap ! $2.584B | |||
| Open | High | Low | Value | Volume |
| $20.11 | $20.34 | $19.63 | $8.874M | 441.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1010 | $20.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.23 | 1443 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |